Commitments and Contingencies (Details)		1 Months Ended		12 Months Ended
	Sep. 03, 2014 USD ($) shares	Mar. 31, 2020 USD ($) $ / shares	Jan. 31, 2020 USD ($)	Dec. 31, 2020 USD ($) m²
Commitments and Contingencies (Details) [Line Items]
Commitments related to agreements				$ 500,000
Maximum payment for commitment milestones				$ 7,900,000
Percentage for royalties				6.00%
Payments of milestone amount				$ 197,000
Office space (in Square Meters) | m²				6,200
Monthly office rent amount before increment				$ 11,625
Rent description				The rent for the last two months of 2019 and the first 10 months of 2020 was approximately $11,883 per month, or approximately $23.00 per square foot, and then decreased to approximately $11,108, or approximately $21.50 per square foot, starting November 2020, which rate will continue for the remainder of the lease period.
Cash paid to acquire Hy Biopharma intangible asset	$ 275,000
Shares issued in connection with Hy BioPharma asset purchase agreement (in Shares) | shares	184,912
Fair value of shares issued in connection with Hy BioPharma asset purchase	$ 3,750,000	$ 1,956,182
Effective price per share (in Dollars per share) | $ / shares		$ 2.56
Additional Payments				$ 5,000,000
Ownership of company outstanding				19.90%
Legal proceedings description				the Company filed a demand for arbitration against Emergent BioSolutions, Inc. and certain of its subsidiaries with the American Arbitration Association in Mercer County, New Jersey. The Company alleges in the arbitration various breaches of contracts and warranties as well as acts of fraud. Emergent has answered that demand for arbitration denying the allegations and asserting affirmative defenses. The Company is seeking to recover damages in excess of $19 million from Emergent. While the Company intends to vigorously pursue this arbitration, the Company cannot offer any assurances that it will recover any damages from Emergent. The Company has received invoices from Emergent related to the above matter. No accrual has been made for these invoices as management deems them invalid and not probable of being required to pay them based on the numerous breaches sited in the pending arbitration. These invoices total approximately $331,000.
Minimum [Member]
Commitments and Contingencies (Details) [Line Items]
Authorized shares to be issued			$ 5,000
Maximum [Member]
Commitments and Contingencies (Details) [Line Items]
Authorized shares to be issued			$ 500,000